Last reviewed · How we verify

NCT06709794: MAPS

Evaluating the Effect of Automatic Plan Assignment and Enhanced Outreach of Marketplace Take-up

ENROLLING BY INVITATION NA Last updated 29 November 2024
What this trial tests

NA trial testing Informational flyer in Outreach Intervention in 30,000 participants. Enrolling by invitation.

Timeline
25 March 2024
Primary endpoint
31 December 2026
31 December 2028

Quick facts

Lead sponsorCovered California
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment30,000
Start date25 March 2024
Primary completion31 December 2026
Estimated completion31 December 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Covered California

Who can join

Eligibility, any sex, with Outreach Intervention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Facilitated enrollment offers a potential solution to some administrative burdens and choice frictions that may produce incomplete take-up of marketplace coverage. Because Covered California, California's ACA individual marketplace, and Medi-Cal, California's Medicaid program, share an eligibility system, Covered California has the ability to identify individuals who are eligible for marketplace coverage upon losing Medicaid eligibility. This evaluation will compare the effectiveness of facilitated enrollment strategies, including personalized plan pre-selection and personalized quotes of net premiums, to other enhanced, but general outreach tactics, on marketplace take-up among individuals losing Medi-Cal coverage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Informational flyer

Trials testing the same drug.

Other recruiting trials for Outreach Intervention

Currently open trials in the same condition.

Other Covered California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06709794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing